EUVIMEDEUVIMED entdecken
Crossref

FDA Approves New Medication for Agitation Associated With Dementia

Samantha Anderer

JAMA · 16.06.2026 · 335 (23) · 2005

DOI: 10.1001/jama.2026.6193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 16.06.2026. Verfasst von Samantha Anderer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Anderer, S. (2026). FDA Approves New Medication for Agitation Associated With Dementia. JAMA, 335(23), 2005. https://doi.org/10.1001/jama.2026.6193

Vancouver

Anderer S. FDA Approves New Medication for Agitation Associated With Dementia. JAMA. 2026;335(23):2005. doi:10.1001/jama.2026.6193

BibTeX
@article{Anderer2026,
  author = {Anderer, Samantha},
  title = {FDA Approves New Medication for Agitation Associated With Dementia},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {23},
  pages = {2005},
  doi = {10.1001/jama.2026.6193}
}
Kostenlos starten →